(Q48787551)

15 February 2018

title

CCK-8 modulates D2 receptor agonist-induced hypermotility in the nucleus accumbens (English)

1 reference

https://api.crossref.org/works/10.1016/0361-9230(91)90020-K

4 December 2022

1 reference

H. Fink

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1828707

4 December 2022

R. Morgenstern

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1828707

4 December 2022

T. Ott

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1828707

4 December 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1828707

4 December 2022

publication date

1 March 1991

1 reference

15 February 2018

full work available at URL

https://api.elsevier.com/content/article/PII:036192309190020K?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0361-9230(91)90020-K

https://api.elsevier.com/content/article/PII:036192309190020K?httpAccept=text/plain

4 December 2022

1 reference

https://api.crossref.org/works/10.1016/0361-9230(91)90020-K

4 December 2022

published in

Brain Research Bulletin

1 reference

15 February 2018

volume

26

1 reference

15 February 2018

page(s)

437-440

1 reference

15 February 2018

issue

3

1 reference

15 February 2018

Obligatory D-1/D-2 receptor interaction in the generation of dopamine agonist related behaviors

cites work

2

1 reference

https://api.crossref.org/works/10.1016/0361-9230(91)90020-K

6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding

4 December 2022

3

1 reference

https://api.crossref.org/works/10.1016/0361-9230(91)90020-K

Central dopamine-peptide interactions: electrophysiological studies

4 December 2022

4

1 reference

https://api.crossref.org/works/10.1016/0361-9230(91)90020-K

Cholecystokinin potentiates dopamine-mediated behaviors: evidence for modulation specific to a site of coexistence

4 December 2022

5

1 reference

https://api.crossref.org/works/10.1016/0361-9230(91)90020-K

Role of D1 and D2 dopamine receptors in mediating locomotor activity elicited from the nucleus accumbens of rats

4 December 2022

7

1 reference

https://api.crossref.org/works/10.1016/0361-9230(91)90020-K

Biphasic effect of D-2 agonist quinpirole on locomotion and movements

4 December 2022

8

1 reference

https://api.crossref.org/works/10.1016/0361-9230(91)90020-K

LSD mescaline and serotonin injected into medial raphe nucleus potentiate apomorphine hypermotility.

4 December 2022

9

1 reference

https://api.crossref.org/works/10.1016/0361-9230(91)90020-K

Antagonism of central and peripheral anorectic effects of caerulein by L-364,718

4 December 2022

11

1 reference

https://api.crossref.org/works/10.1016/0361-9230(91)90020-K

Further evidence for two directions of D-1:D-2 dopamine receptor interaction revealed concurrently in distinct elements of typical and atypical behaviour: studies with the new enantioselective D-2 agonist LY 163502

4 December 2022

13

1 reference

https://api.crossref.org/works/10.1016/0361-9230(91)90020-K

Interaction between accumbens D1 and D2 receptors regulating rat locomotor activity

4 December 2022

14

1 reference

https://api.crossref.org/works/10.1016/0361-9230(91)90020-K

The D2 dopamine receptor agonist LY171555 induces catalepsy in the mouse

4 December 2022

15

1 reference

https://api.crossref.org/works/10.1016/0361-9230(91)90020-K

Penetration of diazepam and the non-peptide CCK antagonist, L-364,718, into rat brain.

4 December 2022

16

1 reference

https://api.crossref.org/works/10.1016/0361-9230(91)90020-K

CCK-8 modulation of mesolimbic dopamine: antagonism of amphetamine-stimulated behaviors.

4 December 2022

17

1 reference

https://api.crossref.org/works/10.1016/0361-9230(91)90020-K

In rats, the behavioral profile of CCK-8 related peptides resembles that of antipsychotic agents.

4 December 2022

18

1 reference

https://api.crossref.org/works/10.1016/0361-9230(91)90020-K

Does cholecystokinin potentiate dopamine action in the nucleus accumbens?

4 December 2022

19

1 reference

https://api.crossref.org/works/10.1016/0361-9230(91)90020-K

Opposite actions of CCK-8 on amphetamine-induced hyperlocomotion and stereotypy following intracerebroventricular and intra-accumbens injections in rats

4 December 2022

20

1 reference

https://api.crossref.org/works/10.1016/0361-9230(91)90020-K

D-1 dopamine receptor stimulation enables the inhibition of nucleus accumbens neurons by a D-2 receptor agonist

4 December 2022

21

1 reference

https://api.crossref.org/works/10.1016/0361-9230(91)90020-K

Is stimulation of both D1 and D2 receptors necessary for the expression of dopamine-mediated behaviors?

4 December 2022

22

1 reference

https://api.crossref.org/works/10.1016/0361-9230(91)90020-K

Neuropharmacological profile of cholecystokinin-like peptides

4 December 2022

23

1 reference

https://api.crossref.org/works/10.1016/0361-9230(91)90020-K

4 December 2022

Identifiers

1 reference

15 February 2018

1 reference

15 February 2018